25.15
Syndax Pharmaceuticals Inc Borsa (SNDX) Ultime notizie
US Market Wrap: Is Syndax Pharmaceuticals Inc a defensive stock2026 Buyback Activity & Consistent Return Investment Signals - baoquankhu1.vn
SNDX Technical Analysis & Stock Price Forecast - Intellectia AI
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Sahm
SNDX Should I Buy - Intellectia AI
Syndax Pharmaceuticals Inc (1T3.MU) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Goldman Sachs Raises Price Target for SNDX to $34, Maintains 'Bu - GuruFocus
Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Price Expected to Rise, The Goldman Sachs Group Analyst Says - MarketBeat
Why (SNDX) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Goldman Sachs Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Maintains Target Price $34 - Moomoo
SNDX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Syndax Pharmaceuticals, Inc. $SNDX Shares Sold by Assenagon Asset Management S.A. - MarketBeat
MACD Signal: What makes Syndax Pharmaceuticals Inc stock attractive today2026 Recap & Consistent Profit Trade Alerts - baoquankhu1.vn
SNDX Analyst Rating Update: Mizuho Lowers Price Target | SNDX St - GuruFocus
Mizuho Securities Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Cuts Target Price to $43 - Moomoo
Syndax Pharmaceuticals (NASDAQ:SNDX) Price Target Cut to $43.00 by Analysts at Mizuho - MarketBeat
Hennion & Walsh Asset Management Inc. Grows Stake in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Entry Recap: Is Syndax Pharmaceuticals Inc a good ESG investment2026 Price Momentum & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
SNDX: Jefferies Adjusts Syndax Pharmaceuticals Price Target to $40 | SNDX Stock News - GuruFocus
Jefferies Financial Group Reiterates "Buy" Rating for Syndax Pharmaceuticals (NASDAQ:SNDX) - MarketBeat
Mizuho lowers Syndax Pharmaceuticals stock price target on sales timing By Investing.com - Investing.com Canada
Syndax Pharmaceuticals Inc (1T3.SG) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Syndax Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript - GuruFocus
Jefferies cuts Syndax Pharmaceuticals stock price target on valuation By Investing.com - Investing.com Canada
Vanguard (NYSE) reports 0 shares in Syndax after realignment (SNDX) - Stock Titan
Syndax (SNDX) Q4 2025 Earnings Call Transcript - AOL.com
Syndax Pharmaceuticals Inc (NASDAQ:SNDX) Emerges as a High-Growth Momentum Pick Using Minervini's Trend Template - ChartMill
Syndax Pharmaceuticals (NASDAQ:SNDX) Hits New 12-Month HighWhat's Next? - MarketBeat
Earnings call transcript: Syndax Pharmaceuticals Q4 2025 revenue beats forecast, stock rises - Investing.com Canada
Hedge Fund Bets: Is Syndax Pharmaceuticals Inc stock showing strong momentumMarket Trend Summary & Daily Price Action Insights - baoquankhu1.vn
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Syndax Pharmaceuticals, Inc. $SNDX Shares Sold by Hudson Bay Capital Management LP - MarketBeat
CEO Moves: Can Syndax Pharmaceuticals Inc stock double in the next yearMarket Activity Report & Community Verified Watchlist Alerts - baoquankhu1.vn
Biotech Stock Up 72% Sees $8 Million Sale, but Here's Why One Fund Still Seems Bullish - AOL.com
This Biotech Stock Winner Is Up 72%, but a $4 Million Trim Signals a Slight Reset - The Motley Fool
DAFNA Capital Reduces Syndax Pharmaceuticals Holding in Q4 2025News and Statistics - IndexBox
Kynam Capital Sells $8.18M in Syndax Shares, Position Value RisesNews and Statistics - IndexBox
Biotech Shares Surge 72% with $8 Million Transaction, Yet This Is Why a Fund Remains Optimistic - Bitget
Understanding Momentum Shifts in (SNDX) - Stock Traders Daily
Syndax Pharmaceuticals stock hits 52-week high at 25.16 USD By Investing.com - Investing.com Canada
Can Syndax Pharmaceuticals Inc scale operations efficiently2026 News Drivers & Fast Moving Stock Watchlists - baoquankhu1.vn
Syndax Pharmaceuticals (NASDAQ:SNDX) Hits New 52-Week HighWhat's Next? - MarketBeat
SNDX SEC FilingsSyndax Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Syndax Pharma: Two Drug Launches Fuel Transformational Growth (NASDAQ:SNDX) - Seeking Alpha
Syndax Pharmaceuticals Q4 2025 earnings preview - MSN
Is It Time To Reassess Syndax Pharmaceuticals (SNDX) After Its 88.5% One Year Surge? - Yahoo Finance
Kingdon Capital Management L.L.C. Purchases 400,000 Shares of Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Granahan Investment Management LLC Has $6.10 Million Stock Position in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Syndax Pharmaceuticals, Inc. $SNDX Shares Acquired by Boothbay Fund Management LLC - MarketBeat
Apis Capital Advisors LLC Takes Position in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Algert Global LLC Cuts Position in Syndax Pharmaceuticals, Inc. $SNDX - MarketBeat
Assessing Whether Syndax Pharmaceuticals (SNDX) Still Looks Undervalued After Its Recent Strong Run - simplywall.st
Syndax Pharmaceuticals, Inc. $SNDX Position Reduced by Prosight Management LP - MarketBeat
Is Syndax Pharmaceuticals (SNDX) Pricing Reflect Its 81.5% One Year Share Price Gain - simplywall.st
Cancer Drug Maker With $172 Million Revenue and Multiple Approved Therapies Draws $6.5 Million Investment - AOL.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):